Literature DB >> 22090501

Distinct mechanisms underlying pronociceptive effects of opioids.

Céline Heinl1, Ruth Drdla-Schutting, Dimitris N Xanthos, Jürgen Sandkühler.   

Abstract

In addition to analgesia, opioids may also produce paradoxical pain amplification [opioid-induced hyperalgesia (OIH)] either on abrupt withdrawal or during continuous long-term application. Here, we assessed antinociceptive and pronociceptive effects of three clinically used opioids at C-fiber synapses in the rat spinal dorsal horn in vivo. During 60 min of intravenous infusions of remifentanil (450 μg·kg⁻¹·h⁻¹), fentanyl (48 μg·kg⁻¹·h⁻¹), or morphine (14 mg·kg⁻¹·h⁻¹), C-fiber-evoked field potentials were depressed and paired-pulse ratios (PPR) were increased, indicating a presynaptic inhibition by all three opioids. After withdrawal, postsynaptic responses were enhanced substantially for the remaining of the recording periods of at least 3 h. Withdrawal from remifentanil led to long-term potentiation (LTP) of synaptic strength in C-fibers via activation of spinal μ-opioid receptors (MORs) and spinal NMDA receptors (NMDARs). Fentanyl and morphine caused an enhancement of synaptic transmission at C-fibers, which involved two distinct mechanisms: (1) an opioid withdrawal LTP that also required activation of spinal MORs and NMDARs and that was associated with a decrease in PPR suggestive of a presynaptic mechanism of its expression, and (2) an immediate-onset, descending facilitation of C-fiber-evoked field potentials during and after intravenous infusion of fentanyl and morphine. Immediate-onset, descending facilitation was mediated by the activation of extraspinal MORs, descending serotonergic pathways, and spinal 5-hydroxytryptamine-3 receptors (5-HT₃Rs). Our study identified fundamentally different pronociceptive effects of clinically used opioids and suggests that OIH can be prevented by the combined use of NMDAR and 5-HT₃R antagonists.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22090501      PMCID: PMC6633307          DOI: 10.1523/JNEUROSCI.3491-11.2011

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  22 in total

1.  Visceral analgesia induced by acute and repeated water avoidance stress in rats: sex difference in opioid involvement.

Authors:  M Larauche; A Mulak; Y S Kim; J Labus; M Million; Y Taché
Journal:  Neurogastroenterol Motil       Date:  2012-07-09       Impact factor: 3.598

2.  Withdrawal from spinal application of remifentanil induces long-term potentiation of c-fiber-evoked field potentials by activation of Src family kinases in spinal microglia.

Authors:  Tao Yang; Sujuan Du; Xianguo Liu; Xijiu Ye; Xuhong Wei
Journal:  Neurochem Res       Date:  2018-06-29       Impact factor: 3.996

3.  Influence of intramuscular heat stimulation on modulation of nociception: complex role of central opioid receptors in descending facilitation and inhibition.

Authors:  Hao-Jun You; Jing Lei; Gang Ye; Xiao-Li Fan; Qiang Li
Journal:  J Physiol       Date:  2014-07-18       Impact factor: 5.182

4.  BDNF released during neuropathic pain potentiates NMDA receptors in primary afferent terminals.

Authors:  Wenling Chen; Wendy Walwyn; Helena S Ennes; Hyeyoung Kim; James A McRoberts; Juan Carlos G Marvizón
Journal:  Eur J Neurosci       Date:  2014-03-11       Impact factor: 3.386

5.  Constitutive μ-opioid receptor activity leads to long-term endogenous analgesia and dependence.

Authors:  G Corder; S Doolen; R R Donahue; M K Winter; B L Jutras; Y He; X Hu; J S Wieskopf; J S Mogil; D R Storm; Z J Wang; K E McCarson; B K Taylor
Journal:  Science       Date:  2013-09-20       Impact factor: 47.728

Review 6.  Pharmacotherapeutic management of co-morbid alcohol and opioid use.

Authors:  Lauren E Hood; Jonna M Leyrer-Jackson; M Foster Olive
Journal:  Expert Opin Pharmacother       Date:  2020-02-27       Impact factor: 3.889

7.  Pronociceptive and Antinociceptive Effects of Buprenorphine in the Spinal Cord Dorsal Horn Cover a Dose Range of Four Orders of Magnitude.

Authors:  Katharina J Gerhold; Ruth Drdla-Schutting; Silke D Honsek; Liesbeth Forsthuber; Jürgen Sandkühler
Journal:  J Neurosci       Date:  2015-07-01       Impact factor: 6.167

8.  Targeting human Mas-related G protein-coupled receptor X1 to inhibit persistent pain.

Authors:  Zhe Li; Pang-Yen Tseng; Vinod Tiwari; Qian Xu; Shao-Qiu He; Yan Wang; Qin Zheng; Liang Han; Zhiping Wu; Anna L Blobaum; Yiyuan Cui; Vineeta Tiwari; Shuohao Sun; Yingying Cheng; Julie H Y Huang-Lionnet; Yixun Geng; Bo Xiao; Junmin Peng; Corey Hopkins; Srinivasa N Raja; Yun Guan; Xinzhong Dong
Journal:  Proc Natl Acad Sci U S A       Date:  2017-02-21       Impact factor: 11.205

9.  Involvement of Spinal PKMζ Expression and Phosphorylation in Remifentanil-Induced Long-Term Hyperalgesia in Rats.

Authors:  Qi Zhao; Linlin Zhang; Ruichen Shu; Chunyan Wang; Yonghao Yu; Haiyun Wang; Guolin Wang
Journal:  Cell Mol Neurobiol       Date:  2016-07-05       Impact factor: 5.046

10.  Multiple inhibitory G-protein-coupled receptors resist acute desensitization in the presynaptic but not postsynaptic compartments of neurons.

Authors:  Reagan L Pennock; Matthew S Dicken; Shane T Hentges
Journal:  J Neurosci       Date:  2012-07-25       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.